MariMed Q2 FY23 Revenue Grows 10.7% YoY, What About Adjusted EBITDA?
MariMed Inc. (OTC: MRMD) (CSE:MRMD) released its financial results for the second quarter ended June 30, 2023, revealing revenue of $36.5 million, an increase of 10.7% compared to $33 million in Q2 2022.
Q2 2023 Financial Highlights